Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss

v3.19.3
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Income Statement [Abstract]        
Revenues $ 0 $ 0 $ 0 $ 0
Operating expenses:        
Research and development 2,785,000 1,332,000 7,816,000 6,801,000
General and administrative 1,672,000 1,248,000 4,748,000 3,859,000
Depreciation and amortization 51,000 11,000 147,000 27,000
Total operating expenses 4,508,000 2,591,000 12,711,000 10,687,000
Loss from operations (4,508,000) (2,591,000) (12,711,000) (10,687,000)
Other income (expense):        
Gain from change in fair value of warrant liability 124,000 573,000 3,059,000 1,614,000
Other income (expense) 5,000 (21,000) 5,000 (23,000)
Interest income, net 5,000 1,000 10,000 5,000
Net loss before taxes (4,374,000) (2,038,000) (9,637,000) (9,091,000)
Income tax benefit 229,000 0 229,000 0
Net loss $ (4,145,000) $ (2,038,000) $ (9,408,000) $ (9,091,000)
Net loss per common share - basic and diluted (usd per share) $ (0.09) $ (0.08) $ (0.24) $ (0.36)
Weighted average common shares outstanding Basic and diluted (shares) 45,464,746 26,861,497 39,034,303 25,373,634
Other comprehensive income (loss):        
Foreign currency translation $ (3,000) $ 15,000 $ (16,000) $ 21,000
Comprehensive loss $ (4,148,000) $ (2,023,000) $ (9,424,000) $ (9,070,000)